All Brands Owned by WW International

Is WW International publicly traded?
Yes, WW International, Inc. is publicly traded on Nasdaq under the ticker symbol WW. The company was delisted during its Chapter 11 bankruptcy filing in May 2025, then relisted on Nasdaq on July 8, 2025, after emerging from bankruptcy. The company had previously been publicly traded since 2004.

Why did WW file for bankruptcy?
WW filed for Chapter 11 bankruptcy in May 2025 to restructure approximately $1.6 billion in debt. The company's debt burden, combined with the disruption caused by GLP-1 weight loss medications to its traditional behavioral business, made the debt unsustainable. The reorganization eliminated $1.15 billion in debt, reducing total debt to $465 million.

What is the difference between WW and Weight Watchers?
WW is the rebranded name for Weight Watchers International, adopted in 2018 to reflect the company's evolution from a sole focus on weight loss to broader health and wellness. The legal name of the company is WW International, Inc. The Weight Watchers brand name is still used in consumer-facing marketing.

How many subscribers does WW have?
WW had 2.5 million total end-of-period subscribers as of Q2 2026. This includes 2.29 million behavioral subscribers (down 24.6 percent year over year) and 197,000 clinical subscribers (up 55.7 percent year over year). Core+ subscribers were 541,000, up 13.9 percent year over year.

Who is the CEO of WW International?
WW International is currently led by an Interim Office of the Chief Executive, with Jon Volkmann (Chief Operations Officer) and Felicia DellaFortuna (Chief Financial Officer) sharing executive responsibilities. The previous CEO, Tara Comonte, departed after the company's emergence from bankruptcy in 2025. The company is searching for a permanent CEO.

What is WW's Clinical business?
WW's Clinical business, operated through its Sequence subsidiary, provides telehealth access to clinicians who can prescribe GLP-1 weight management medications, lab work, and ongoing medical supervision. Clinical subscription revenue was $39.9 million in Q2 2026, up 30.4 percent year over year, and accounted for 24.6 percent of total revenue.

What is WW's revenue?
WW reported Q2 2026 revenue of $162.3 million, down 14.2 percent from $189.2 million in Q2 2025. The decline was driven by a 22.7 percent drop in behavioral subscription revenue, partially offset by 30.4 percent growth in clinical subscription revenue. The company has reaffirmed its full-year 2026 revenue and adjusted EBITDA guidance.